SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19 – New England Journal of Medicine Audio Interview: A New Monoclonal Antibody for Covid-19 – New England Journal of Medicine   Commentaries on Twitter BLAZE-1? – outpatient trial of LY-Cov555, mAb recently dropped from ACTIV-3 inpatient trial Only 1 of the 3 mAb dosages (middle one ?‍♂️) […]

The post Randomized phase 2 trial: SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19 appeared first on Links Medicus.